Uniti Group Inc. to Participate in the Wells Fargo 9th Annual Virtual Net Lease REIT Forum
LITTLE ROCK, Ark., Sept. 03, 2020 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its Executive […]
BRP Group, Inc. to Participate in the 2020 KBW Insurance Conference
TAMPA, Fla., Sept. 03, 2020 (GLOBE NEWSWIRE) — BRP Group, Inc. (“BRP Group” or the “Company”) (NASDAQ: BRP), a rapidly […]
Equillium to Present at H.C. Wainwright 22nd Annual Global Investment Conference
LA JOLLA, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding […]
Inozyme Pharma Reports Second Quarter 2020 Financial Results and Provides Business Highlights
Upsized IPO in July 2020 raised $128.8 million in gross proceedsSubmitted IND for INZ-701 for the treatment of ENPP1 deficiency; currently […]
Alector to Participate at Virtual Investor Conferences in September
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today […]
HBT Financial, Inc. Announces Issuance of $40 Million in Subordinated Notes
BLOOMINGTON, Ill., Sept. 03, 2020 (GLOBE NEWSWIRE) — HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial”), the holding […]
Proofpoint Enhances Security Awareness Training Platform, Integrates Best-in-Class Threat Intelligence with People-centric Innovations
SUNNYVALE, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) — Proofpoint, Inc., (NASDAQ: PFPT), a leading cybersecurity and compliance company, today announced […]
Exagen to Participate in 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for […]
AGTC to Participate at Upcoming Virtual Investor Conferences
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company […]
Relay Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Trial of RLY-4008, a Highly Selective FGFR2 Inhibitor
CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the […]
